BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
143 results:

  • 1. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
    Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
    Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endocrine tumors of the female reproductive tract.
    Asa SL; Ezzat S
    Mol Cell Endocrinol; 2024 Mar; 582():112123. PubMed ID: 38135144
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and ovarian cancer.
    Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
    JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer.
    Adamson AW; Ding YC; Steele L; Leong LA; Morgan R; Wakabayashi MT; Han ES; Dellinger TH; Lin PS; Hakim AA; Wilczynski S; Warden CD; Tao S; Bedell V; Cristea MC; Neuhausen SL
    J Ovarian Res; 2023 Jul; 16(1):141. PubMed ID: 37460928
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.
    Yeo XH; Sundararajan V; Wu Z; Phua ZJC; Ho YY; Peh KLE; Chiu YC; Tan TZ; Kappei D; Ho YS; Tan DSP; Tam WL; Huang RY
    Commun Biol; 2023 Jun; 6(1):660. PubMed ID: 37349576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. stk11 Adnexal Tumor in an Adolescent Female: Diagnostic Pitfalls of a Recently Described Entity.
    Sharma AE; Slack JC; Parra-Herran CE; Quade BJ; Shusterman S; Church AJ; Kolin DL; Carreon CK
    Pediatr Dev Pathol; 2023; 26(5):486-493. PubMed ID: 37334562
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline
    Yoshida H; Hiranuma K; Nakahara M; Kobayashi-Kato M; Tanase Y; Uno M; Shiraishi K; Ishikawa M; Kato T
    Int J Surg Pathol; 2024 Apr; 32(2):394-400. PubMed ID: 37226494
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. AMPK-like proteins and their function in female reproduction and gynecologic cancer.
    Baumgartner C; Yadav AK; Chefetz I
    Adv Protein Chem Struct Biol; 2023; 134():245-270. PubMed ID: 36858738
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prevalence of Pathogenic Germline Mutations in 13 Hereditary cancer-Related Genes in Breast cancer Patients in Narathiwat Province, Thailand.
    Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Bilateral Peutz-Jeghers-Associated Sex Cord Tumor With Annular Tubules Combined With Unilateral Adult Granulosa Cell Tumor: A Case Report.
    Feng YY; Li Z; Zhang MH
    Int J Surg Pathol; 2023 Oct; 31(7):1352-1358. PubMed ID: 36710570
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular characteristics of low-grade serous carcinoma in effusions.
    Doutel D; Davidson B; Nitschke Pettersen IK; Torgunrud A
    Cytopathology; 2023 Mar; 34(2):99-105. PubMed ID: 36609991
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of a Molecularly-Defined Subset of Breast and ovarian cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.
    Serra V; Wang AT; Castroviejo-Bermejo M; Polanska UM; Palafox M; Herencia-Ropero A; Jones GN; Lai Z; Armenia J; Michopoulos F; Llop-Guevara A; Brough R; Gulati A; Pettitt SJ; Bulusu KC; Nikkilä J; Wilson Z; Hughes A; Wijnhoven PWG; Ahmed A; Bruna A; Gris-Oliver A; Guzman M; Rodríguez O; Grueso J; Arribas J; Cortés J; Saura C; Lau A; Critchlow S; Dougherty B; Caldas C; Mills GB; Barrett JC; Forment JV; Cadogan E; Lord CJ; Cruz C; Balmaña J; O'Connor MJ
    Clin Cancer Res; 2022 Oct; 28(20):4536-4550. PubMed ID: 35921524
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
    Bennett C; Suguitan M; Abad J; Chawla A
    Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The complex and often confusing history, histology and histogenesis of mesonephric, stk11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament).
    Bennett JA; Oliva E
    Histopathology; 2022 Sep; 81(3):280-296. PubMed ID: 35395118
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer genetics and breast cancer.
    Huber-Keener KJ
    Best Pract Res Clin Obstet Gynaecol; 2022 Jun; 82():3-11. PubMed ID: 35272929
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.